As leading experts in autoimmune diseases and therapies, we focus on treatments that will improve the standard of care for this generation and the next.
Exploring Uncharted Territories of Treatment
We continue to push innovation within our immunology pipeline—considering multiple scientific approaches and investigating novel solutions to help improve patient care across a variety of autoimmune diseases with unmet needs.
150+ active clinical trials in immunology
6 new molecular compounds in Phase I, II or III clinical trials in immunology
9 immune-mediated inflammatory conditions being investigated
50+ countries with active clinical trials in immunology